Arcticzymes Technologies ASA
F:B4V

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
F:B4V
Watchlist
Price: 1.8 EUR 0.84% Market Closed
Market Cap: 91.9m EUR

Operating Margin
Arcticzymes Technologies ASA

-7.8%
Current
12%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7.8%
=
Operating Profit
-7.7m
/
Revenue
97.9m

Operating Margin Across Competitors

No Stocks Found

Arcticzymes Technologies ASA
Glance View

Market Cap
91.9m EUR
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

B4V Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7.8%
=
Operating Profit
-7.7m
/
Revenue
97.9m
What is the Operating Margin of Arcticzymes Technologies ASA?

Based on Arcticzymes Technologies ASA's most recent financial statements, the company has Operating Margin of -7.8%.

Back to Top